Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

OPTIRAY 320

IOVERSOL

Standard Dose
68%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview OPTIRAY 320 is listed in Drugs@FDA under application 019710 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient IOVERSOL Form and strength INJECTABLE;INJECTION - 68% Sponsor LIEBEL-FLARSHEIM Submission history Latest submission status date: 2023-04-25 00:00:00.

Structured Monograph

Clinical summary

Approval overview OPTIRAY 320 is listed in Drugs@FDA under application 019710 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient IOVERSOL Form and strength INJECTABLE;INJECTION - 68% Sponsor LIEBEL-FLARSHEIM Submission history Latest submission status date: 2023-04-25 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.